Major pharma to license catnip repellent within 12 months

A pharmaceutical company will acquire rights to commercialize the catnip-based repellent formula from the study team. This will trigger regulatory filings in the EU and US within 12 months, accelerating global distribution.

regulatory · Prediction Market

Implied probability (Yes)

68%

Closes

2027-06-30

More regulatory markets

• UK government increases teacher pay offer by 2%+ in 2027 — 45% Yes
• FIFA issues formal disciplinary action against Trump by 2026-12-31 — 70% Yes
• UK government to allocate £200M for river clean-up by 2026 — 70% Yes
• FIFA issues formal reprimand against U.S. Soccer for Trump interference — 75% Yes
• Trump administration implements AI guardrails by Q4 2026 — 70% Yes
• FIFA reinstates Balogun suspension within 30 days — 70% Yes
• Mississippi will revoke xAI's turbine loophole by Q4 2026 — 75% Yes
• Forge Global secures Anthropic approval within 6 months — 75% Yes

Browse all regulatory markets →